thunderclap logo
loading
×
×
×
×
×

#TestTreatPrevent

by European HIV-Hepatitis Testing Week 2017 category: Health

“#EuroTestWeek starts TODAY. Help us raise awareness on #HIV and #Hepatitis! #TestTreatPrevent http://thndr.me/ZMH1Bw

profile image
European HIV-Hepatitis Testing Week 2017
Supporters
120 of 100
120% of goal supported
Social Reach
147,379
People
Time Left
Complete

Complete

This campaign ended on November 17, 2017 at 9AM

#TestTreatPrevent

European HIV-Hepatitis Testing Week takes place from 17-24 November 2017.

The ultimate goal of European HIV-Hepatitis Testing Week is to make more people aware of their HIV and/ or hepatitis status and reduce late diagnosis by communicating the benefits of testing. The theme for testing week is Test. Treat. Prevent., with the aim of supporting ongoing dialogue between all partners in the HIV and hepatitis communities, in order to:

  • Encourage people who could be at risk of HIV and/or hepatitis to get tested
  • Encourage healthcare professionals to offer an HIV and/or hepatitis test as part of routine care in specific settings and conditions (in line with present European guidelines)
  • Support and unite community organisations to scale up access to HIV and hepatitis testing and share lessons learned between countries
  • Make more policy makers aware of the individual, societal and economic benefits of HIV and hepatitis testing initiatives and how to evaluate testing practices.

Why is the European HIV-Hepatitis Testing Week taking place?
Today, at least one in four of the 1.2 million people living with HIV in Europe are unaware that they are HIV positive. Nearly half of those living with HIV are diagnosed late – which delays access to treatment.

In 2016, 519 organisations took part in European HIV-Hepatitis Testing Week with almost 90% of all participants carrying out testing activities.

Hepatitis B and C are common among people at risk of and living with HIV. Around 13.3 million people are living with hepatitis B in the WHO European Region; approximately 20-30% of infected individuals will develop cirrhosis, liver failure or hepatocellular carcinoma. 15 million people in the WHO European Region are living with hepatitis C; however, the majority of people with hepatitis C remain undiagnosed and only a small minority in Europe (3.5%) receive treatment.

For more information, please visit: http://www.testingweek.eu and to sign-up please visit: http://www.testingweek.eu/register-to-take-part.aspx


Organizer

European HIV-Hepatitis Testing Week 2017
@HIVheptestweek

Testing Week 2017 offers partners across Europe the opportunity to unite for one week to increase awareness regarding the benefits of HIV and hepatitis testing, so that more people become knowledgeable about their risks, understand that there is effective treatment available and are aware of their HIV and/ or hepatitis status.

Recent Supporters
profile pic


1 day ago

profile pic

Iva Jovovic
1 day ago

profile pic

AIDS Action Europe
2 days ago

profile pic

Oksana Panochenko
2 days ago

profile pic

Ioan Petre
2 days ago

profile pic

Labcold
2 days ago

profile pic

Meaghan Kall
2 days ago

profile pic

Meaghan Kall
2 days ago

×